Patents by Inventor Sarah L. Bolt

Sarah L. Bolt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Humanized anti-CD3 specific antibodies
    Publication number: 20040202657
    Abstract: Novel aglycosylated antibodies having a binding affinity for the CD3 antigen complex are of value for use in therapy, particularly in immunosuppression.
    Type: Application
    Filed: December 23, 2003
    Publication date: October 14, 2004
    Applicant: BTG International Limited
    Inventors: Sarah L. Bolt, Michael R. Clark, Scott D. Gorman, Edward G. Routledge, Herman Waldman
  • Humanized anti-CD3 specific antibodies
    Patent number: 6706265
    Abstract: Novel aglycosylated antibodies having a binding affinity for the CD3 antigen complex are of value for use in therapy, particularly in immunosuppression.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 16, 2004
    Assignee: BTG International Limited
    Inventors: Sarah L. Bolt, Michael R. Clark, Scott D. Gorman, Edward G. Routledge, Herman Waldmann
  • Humanized anti-CD3 specific antibodies
    Patent number: 5585097
    Abstract: Novel aglycosylated antibodies having a binding affinity for the CD3 antigen complex are of value for use in therapy, particularly in immunosuppression.
    Type: Grant
    Filed: November 8, 1993
    Date of Patent: December 17, 1996
    Assignee: British Technology Group Limited
    Inventors: Sarah L. Bolt, Michael R. Clark, Scott D. Gorman, Edward G. Routledge, Herman Waldmann